금융 뉴스 허브
실시간 글로벌 금융 시장 뉴스 · 분석 · 인사이트
BREAKING주요 뉴스
WTI holds ground above $84.50 as escalating concerns over US sanctions on Iran
West Texas Intermediate (WTI) oil price appreciates after registering over 2% losses in the previous...
RBA Minutes: Board ready to raise rates if upside risks materialise
Reserve Bank of Australia (RBA) published the Minutes of its July monetary policy meeting on Tuesday...
Euro gains support amid hawkish ECB expectations, subdued US Dollar
EUR/USD inches higher after posting minor losses in the previous day, trading around 1.1670 during t...
Qatar launches mediation effort with Iran to ease tensions over Strait of Hormuz
Qatar has dispatched negotiators to Iran for meetings with Iranian officials in a renewed diplomatic effort to de-escalate tensions and create conditions for broader negotiations to continue, accordin ...
Buying stocks at all-time highs still returned 10.5% a year since 1950 — here's why boomers should hold steady
Investing at all-time highs seems like a bad move, but the data suggests the timing isn’t everything.
WTI price holds near $72 amid hopes of US-Iran de-escalation
West Texas Intermediate (WTI) Oil trades around $72 at the time of writing on Friday, up 0.42% on the day, but remains in a consolidation phase after reaching a more than two-week high earlier this we ...
Cadiz wins BLM approval for right-of-way to convert pipeline for water use
U.S.-Belgium World Cup match sets U.S. soccer viewership record
Financial funds steal the spotlight with biggest inflow since January, BofA says
New Zealand Dollar: Constructive outlook faces yield constraints – OCBC
OCBC strategists Christopher Wong and Sim Moh Siong note that the New Zealand Dollar (NZD) outperformed after stronger manufacturing data and hawkish Reserve Bank of New Zealand (RBNZ) commentary rein ...
Federated Hermes Premier Municipal Income Fund declares $0.045 dividend
HSBC's top picks heading into earnings season
MTY Food Group Inc. declares CAD 0.37 dividend
Sanofi wins FDA nod for injectable multiple myeloma therapy
Where Analysts Pushed Back On DRI's Latest Call
Darden's headline numbers looked solid, but analysts on its latest call kept probing the one real tension: with Olive Garden slowing, can the rest of the portfolio carry the weight.